# Dhaliwal Pharmaceuticals Laboratories, LLC – FDA Inspection, Sep 16, 2026

Source: https://www.keypedia.com/records/fda_inspections/dhaliwal-pharmaceuticals-laboratories-llc/995950bd-0c08-4e96-83ae-3b8e535c47dd
Source feed: FDA_Inspections

> FDA inspection 1336074 of Dhaliwal Pharmaceuticals Laboratories, LLC, September 16, 2026. 1 citation under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1336074
- Company Name: Dhaliwal Pharmaceuticals Laboratories, LLC
- Inspection Date: 2026-09-16
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1163548 - 2022-03-01](https://www.keypedia.com/records/fda_inspections/dhaliwal-pharmaceuticals-laboratories-llc/617782f6-6384-43ab-bb87-24cd1361681d)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kevin-t-nguyen/5ae9d562-7e4f-4305-895a-4b39c35acd16)

Company: https://www.keypedia.com/companies/dhaliwal-pharmaceuticals-laboratories-llc/6b73fbe1-22b4-4f57-a4f9-74246f77b9b9

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9